Chandler Park’s Insights on the SunRISe Program and the Potential of TAR-200 for High-Risk Bladder Cancer
Chandler Park, Kentucky Physician Representative at ASCO State Executive Council, shared a post by Topline Bio on LinkedIn:
”Appreciate Topline Bio for the opportunity to discuss our practice changing SunRISe Bladder Cancer study.
Thank you to all of our patients that have enrolled in this study in Louisville, Kentucky.
Also grateful for the outstanding leadership of Ryan Malone, First Urology PSC and Norton Cancer Insitute for coming together on this research project.
Our team is honored to be the highest enrollers in the United States of America.”
Quoting Topline Bio‘s post:
”Listen in to Chandler Park‘s colorful Topline Take on the SunRISe program and the potential of of the investigational TAR-200 for patients with high-risk non-muscle-invasive bladder cancer as an innovative targeted release system.
We thank Park for his passion and commitment to patient care.”
Chandler Park, MD, FACP is an haematologist oncologist, medical journalist, and clinical researcher. He is the Advisory Dean and Clinical Professor at University of Louisville School of Medicine. He is the Kentucky Physician Representative of the ASCO State Executive Council. He is also the Medical Oncology Board Examiner at American Board of Internal Medicine.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023